<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Tool Diagnostico Lesioni Basaloidi - v15.6</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Segoe UI', sans-serif; line-height: 1.6; color: #333; background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); padding: 20px; min-height: 100vh; }
        .container { max-width: 1200px; margin: 0 auto; background: white; border-radius: 20px; box-shadow: 0 20px 60px rgba(0,0,0,0.3); overflow: hidden; }
        header { background: linear-gradient(135deg, #1e3c72 0%, #2a5298 100%); color: white; padding: 30px; text-align: center; }
        header h1 { font-size: 2em; margin-bottom: 10px; }
        .content { padding: 30px; }
        .section { margin-bottom: 30px; border: 2px solid #e0e0e0; border-radius: 10px; overflow: hidden; transition: all 0.3s; }
        .section-header { background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; padding: 15px 20px; cursor: pointer; display: flex; justify-content: space-between; font-weight: bold; font-size: 1.2em; }
        .section-content { padding: 20px; display: none; }
        .section-content.active { display: block; }
        .checkbox-group { display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 15px; margin: 20px 0; }
        .checkbox-item { display: flex; align-items: center; padding: 12px; background: #f8f9fa; border-radius: 8px; }
        .checkbox-item input { margin-right: 10px; width: 20px; height: 20px; cursor: pointer; }
        .checkbox-item label { cursor: pointer; flex: 1; }
        .result-box { background: #f0f8ff; border-left: 5px solid #2196F3; padding: 20px; margin: 20px 0; border-radius: 5px; }
        .result-box.warning { background: #fff3cd; border-left-color: #ffc107; }
        .result-box.danger { background: #f8d7da; border-left-color: #dc3545; }
        .result-box.success { background: #d4edda; border-left-color: #28a745; }
        .result-box.blocked { background: #f1f1f1; border-left-color: #6c757d; }
        table { width: 100%; border-collapse: collapse; margin: 20px 0; font-size: 0.9em; }
        table th { background: #667eea; color: white; padding: 12px; text-align: left; }
        table td { padding: 12px; border-bottom: 1px solid #e0e0e0; }
        .badge { display: inline-block; padding: 5px 10px; border-radius: 20px; font-size: 0.85em; font-weight: bold; margin: 5px; }
        .badge-success { background: #28a745; color: white; }
        .badge-danger { background: #dc3545; color: white; }
        .badge-warning { background: #ffc107; color: #333; }
        .badge-info { background: #17a2b8; color: white; }
        .badge-secondary { background: #6c757d; color: white; }
        button { background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; border: none; padding: 12px 30px; border-radius: 25px; cursor: pointer; font-size: 1em; font-weight: bold; margin: 10px 5px; transition: all 0.2s; }
        button:hover { transform: translateY(-2px); box-shadow: 0 5px 15px rgba(0,0,0,0.2); }
        .alert { padding: 15px; border-radius: 8px; margin: 15px 0; font-weight: 500; }
        .alert-warning { background: #fff3cd; border: 2px solid #ffc107; color: #856404; }
        .alert-danger { background: #f8d7da; border: 2px solid #dc3545; color: #721c24; }
        .alert-info { background: #d1ecf1; border: 2px solid #17a2b8; color: #0c5460; }
        .alert-secondary { background: #e9ecef; border: 2px solid #6c757d; color: #495057; }
        .alert-blocked { background: #f1f1f1; border: 2px solid #6c757d; color: #333; font-size: 1em; }
        h3 { color: #667eea; margin: 20px 0 10px 0; font-size: 1.4em; }
        h4 { color: #764ba2; margin: 15px 0 10px 0; font-size: 1.1em; }
        ul { margin-left: 20px; margin-top: 10px; }
        li { margin: 8px 0; }
        ol { margin-left: 20px; margin-top: 10px; }
        .variant-card { background: white; border: 2px solid #e0e0e0; border-radius: 10px; padding: 20px; margin: 15px 0; }
        .variant-card.low-risk { border-left: 5px solid #28a745; }
        .variant-card.high-risk { border-left: 5px solid #dc3545; }
        footer { background: #2a5298; color: white; text-align: center; padding: 20px; font-size: 0.9em; }
        footer a { color: #fff; text-decoration: none; font-weight: bold; }
        .toggle-icon { transition: transform 0.3s; }
        .toggle-icon.rotated { transform: rotate(180deg); }
        .flowchart-container { background: white; padding: 30px; border-radius: 10px; margin: 20px 0; overflow-x: auto; }
        mark { background: #ffeb3b; padding: 2px 4px; border-radius: 3px; }
        .bib-link { color: #667eea; text-decoration: none; font-weight: bold; margin: 0 5px; font-size: 0.95em; padding: 2px 8px; background: #f0f4ff; border-radius: 4px; transition: all 0.2s; display: inline-block; }
        .bib-link:hover { text-decoration: underline; color: #764ba2; background: #e0e8ff; transform: translateY(-1px); box-shadow: 0 2px 5px rgba(0,0,0,0.1); }
        .disclaimer { font-size: 0.85em; color: #6c757d; font-style: italic; margin-top: 10px; padding: 8px 12px; background: #f8f9fa; border-radius: 5px; border-left: 3px solid #6c757d; }
        /* v15.5: IHC intensity selector */
        .ihc-row { display: flex; align-items: center; padding: 10px 12px; background: #f8f9fa; border-radius: 8px; gap: 10px; }
        .ihc-row label { flex: 1; cursor: pointer; font-size: 0.95em; }
        .ihc-row select { padding: 4px 8px; border-radius: 5px; border: 1px solid #ccc; font-size: 0.85em; background: white; }
        .ihc-group-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 10px; margin: 15px 0; }
        @media (max-width: 768px) { 
            .checkbox-group { grid-template-columns: 1fr; } 
            .ihc-group-grid { grid-template-columns: 1fr; }
            header h1 { font-size: 1.5em; } 
            .content { padding: 15px; }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>üî¨ Tool Diagnostico Lesioni Basaloidi</h1>
            <p>Evidence-Based ‚Ä¢ v15.6 ‚Ä¢ 2026</p>
            <p style="font-size:0.8em; opacity:0.8; margin-top:5px;">Fix: Score morfologico riequilibrato | Zona H+MAC alert | Ber-EP4 focale/infiltrativo | p63/CK5/6 MAC wording | Margini MAC aggiornati</p>
        </header>

        <div class="content">

            <!-- ============================================================ -->
            <!-- CLINICAL INPUT -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('clinical')">
                    <span>üìã INPUT CLINICO (obbligatorio per accuratezza)</span>
                    <span class="toggle-icon" id="clinical-icon">‚ñº</span>
                </div>
                <div class="section-content active" id="clinical-content">
                    <div class="alert alert-warning"><strong>‚ö†Ô∏è Compila prima di procedere.</strong> Sede e tipo di biopsia condizionano la logica diagnostica ‚Äî in particolare il safeguard MAC.</div>
                    <div class="checkbox-group">
                        <div class="checkbox-item" style="flex-direction: column; align-items: flex-start;">
                            <label for="clinical-site"><strong>Sede anatomica:</strong></label>
                            <select id="clinical-site" style="width: 100%; padding: 8px; margin-top: 5px; border-radius: 5px; border: 1px solid #ccc;" onchange="updateClinicalWarnings()">
                                <option value="">-- Seleziona --</option>
                                <option value="h-zone">Zona H (naso, perioculare, orecchio, labbra)</option>
                                <option value="face-other">Volto (non zona H)</option>
                                <option value="scalp">Cuoio capelluto</option>
                                <option value="trunk">Tronco</option>
                                <option value="limbs">Arti</option>
                                <option value="palmoplantar">Palmo/Pianta</option>
                                <option value="genital">Genitale/perigenitale</option>
                            </select>
                        </div>
                        <div class="checkbox-item" style="flex-direction: column; align-items: flex-start;">
                            <label for="clinical-biopsy"><strong>Tipo biopsia:</strong></label>
                            <select id="clinical-biopsy" style="width: 100%; padding: 8px; margin-top: 5px; border-radius: 5px; border: 1px solid #ccc;" onchange="updateClinicalWarnings()">
                                <option value="">-- Seleziona --</option>
                                <option value="punch-superficial">Punch superficiale / shave (‚â§3mm o tangenziale)</option>
                                <option value="punch-deep">Punch profondo (&gt;3mm, sottocute incluso)</option>
                                <option value="incisional">Incisionale profonda</option>
                                <option value="excisional">Escissionale completa</option>
                            </select>
                        </div>
                        <div class="checkbox-item">
                            <input type="checkbox" id="clinical-recurrence" name="clinical" onchange="updateClinicalWarnings()">
                            <label for="clinical-recurrence">Recidiva su precedente trattamento</label>
                        </div>
                        <div class="checkbox-item">
                            <input type="checkbox" id="clinical-immunosupp" name="clinical" onchange="updateClinicalWarnings()">
                            <label for="clinical-immunosupp">Paziente immunosoppresso (trapianto, HIV, biologici)</label>
                        </div>
                    </div>
                    <div id="clinical-warnings"></div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- FLOWCHART -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('flowchart')">
                    <span>üìä ALGORITMO DIAGNOSTICO INTERATTIVO</span>
                    <span class="toggle-icon" id="flowchart-icon">‚ñº</span>
                </div>
                <div class="section-content" id="flowchart-content">
                    <div class="flowchart-container">
                        <svg viewBox="0 0 900 1150" style="width: 100%; max-width: 900px; margin: 0 auto; display: block;">
                            <g onclick="alert('üî¨ START: Proliferazione basaloide cutanea')">
                                <rect x="350" y="20" width="200" height="60" rx="10" fill="#667eea" stroke="#1e3c72" stroke-width="2"/>
                                <text x="450" y="55" text-anchor="middle" fill="white" font-weight="bold" font-size="14">Proliferazione Basaloide</text>
                            </g>
                            <line x1="450" y1="80" x2="450" y2="120" stroke="#333" stroke-width="2" marker-end="url(#arrowhead)"/>
                            <g>
                                <rect x="300" y="120" width="300" height="70" rx="10" fill="#ffd700" stroke="#ff8c00" stroke-width="2"/>
                                <text x="450" y="145" text-anchor="middle" font-weight="bold" font-size="13">Pattern BCC-like?</text>
                                <text x="450" y="163" text-anchor="middle" font-size="10">(palizzata + retrazione/clefting)</text>
                                <text x="450" y="179" text-anchor="middle" font-size="9" fill="#666">‚ö†Ô∏è Valutabile anche su shave, ma non esclude MAC infiltrativo profondo</text>
                            </g>
                            <line x1="350" y1="190" x2="200" y2="240" stroke="#28a745" stroke-width="3" marker-end="url(#arrowhead)"/><text x="250" y="210" fill="#28a745" font-weight="bold">S√å</text>
                            <line x1="550" y1="190" x2="700" y2="240" stroke="#dc3545" stroke-width="3" marker-end="url(#arrowhead)"/><text x="640" y="210" fill="#dc3545" font-weight="bold">NO</text>
                            <g>
                                <rect x="80" y="240" width="240" height="70" rx="10" fill="#ffd700" stroke="#ff8c00" stroke-width="2"/>
                                <text x="200" y="265" text-anchor="middle" font-weight="bold" font-size="13">Ber-EP4 positivo</text>
                                <text x="200" y="283" text-anchor="middle" font-size="10">diffuso o focale?</text>
                                <text x="200" y="299" text-anchor="middle" font-size="9" fill="#666">(scegli intensit√† nel panel IHC)</text>
                            </g>
                            <line x1="200" y1="310" x2="200" y2="350" stroke="#28a745" stroke-width="3" marker-end="url(#arrowhead)"/><text x="215" y="335" fill="#28a745" font-weight="bold">S√å</text>
                            <g onclick="alert('‚úÖ BCC fortemente suggestivo!\nSe piccolo/simmetrico + Ber-EP4 solo focale: DD trichoepithelioma.\nSe EMA+ focale: valuta basosquamoso.')">
                                <rect x="60" y="350" width="280" height="105" rx="10" fill="#28a745" stroke="#155724" stroke-width="2"/>
                                <text x="200" y="378" text-anchor="middle" fill="white" font-weight="bold" font-size="15">BCC (fortemente suggestivo)</text>
                                <text x="200" y="398" text-anchor="middle" fill="white" font-size="10">Valutare variante istologica</text>
                                <text x="200" y="416" text-anchor="middle" fill="white" font-size="9">Ber-EP4 solo focale + simmetria</text>
                                <text x="200" y="430" text-anchor="middle" fill="white" font-size="9">‚Üí DD trichoepithelioma</text>
                                <text x="200" y="445" text-anchor="middle" fill="white" font-size="9">EMA+ focale ‚Üí DD basosquamoso</text>
                            </g>
                            <line x1="100" y1="310" x2="60" y2="480" stroke="#dc3545" stroke-width="3" marker-end="url(#arrowhead)"/><text x="42" y="395" fill="#dc3545" font-weight="bold">NO</text>
                            <g>
                                <rect x="20" y="480" width="200" height="75" rx="10" fill="#ffd700" stroke="#ff8c00" stroke-width="2"/>
                                <text x="120" y="505" text-anchor="middle" font-weight="bold" font-size="12">Stroma CD10/CD34+?</text>
                                <text x="120" y="523" text-anchor="middle" font-size="9">+ architettura simmetrica</text>
                                <text x="120" y="538" text-anchor="middle" font-size="9">+ papille stromali</text>
                            </g>
                            <line x1="120" y1="555" x2="120" y2="600" stroke="#28a745" stroke-width="3" marker-end="url(#arrowhead)"/><text x="135" y="582" fill="#28a745" font-weight="bold">S√å</text>
                            <g onclick="alert('üî∑ Lesione follicolare!\nTricoblastoma/Trichoepithelioma.\nNota: Ber-EP4 pu√≤ essere focale+ in alcuni trichoepitheliomi (variabilit√† clone).')">
                                <rect x="20" y="600" width="200" height="95" rx="10" fill="#9c27b0" stroke="#6a1b9a" stroke-width="2"/>
                                <text x="120" y="628" text-anchor="middle" fill="white" font-weight="bold" font-size="14">FOLLICOLARE</text>
                                <text x="120" y="648" text-anchor="middle" fill="white" font-size="10">Tricoblastoma/Trichoepit.</text>
                                <text x="120" y="666" text-anchor="middle" fill="white" font-size="8">‚ö†Ô∏è Ber-EP4 focale+ possibile</text>
                                <text x="120" y="680" text-anchor="middle" fill="white" font-size="8">nei trichoepitheliomi (raro)</text>
                            </g>
                            <line x1="200" y1="555" x2="270" y2="600" stroke="#dc3545" stroke-width="3" marker-end="url(#arrowhead)"/><text x="248" y="572" fill="#dc3545" font-weight="bold" font-size="10">NO</text>
                            <g onclick="alert('‚ö†Ô∏è IHC non conclusivo!\nPanel esteso:\nAdipofil. ‚Üí sebaceo\nGATA3/TTF1/CDX2 ‚Üí metastasi\nSOX10 ‚Üí melanocitario')">
                                <rect x="230" y="600" width="200" height="95" rx="10" fill="#6c757d" stroke="#495057" stroke-width="2"/>
                                <text x="330" y="625" text-anchor="middle" fill="white" font-weight="bold" font-size="12">IHC NON CONCLUSIVO</text>
                                <text x="330" y="645" text-anchor="middle" fill="white" font-size="9">Adipofilina ‚Üí sebaceo</text>
                                <text x="330" y="660" text-anchor="middle" fill="white" font-size="8">GATA3/TTF1/CDX2 ‚Üí metastasi</text>
                                <text x="330" y="675" text-anchor="middle" fill="white" font-size="8">SOX10/S100 ‚Üí melanocitario</text>
                            </g>
                            <!-- NO pattern BCC branch -->
                            <g>
                                <rect x="580" y="240" width="240" height="75" rx="10" fill="#ffd700" stroke="#ff8c00" stroke-width="2"/>
                                <text x="700" y="265" text-anchor="middle" font-weight="bold" font-size="13">Duttali BEN DEFINITI?</text>
                                <text x="700" y="283" text-anchor="middle" font-size="9">(lumi, cuticole, no pseudo-duttali)</text>
                                <text x="700" y="300" text-anchor="middle" font-size="8" fill="#666">Correlare con sede (palmo=poroma‚Üë)</text>
                            </g>
                            <line x1="640" y1="315" x2="550" y2="360" stroke="#28a745" stroke-width="3" marker-end="url(#arrowhead)"/><text x="572" y="333" fill="#28a745" font-weight="bold">S√å</text>
                            <g onclick="alert('üíß Lesione eccrina!\nDD: Poroma/Spiroadenoma/Siringoma/Idroadenoma.\nCorrelare con sede.\nPalmo/pianta ‚Üí Poroma in primis.')">
                                <rect x="460" y="360" width="180" height="95" rx="10" fill="#17a2b8" stroke="#117a8b" stroke-width="2"/>
                                <text x="550" y="390" text-anchor="middle" fill="white" font-weight="bold" font-size="14">LESIONE ECCRINA</text>
                                <text x="550" y="410" text-anchor="middle" fill="white" font-size="9">Poroma/Spiroadenoma</text>
                                <text x="550" y="425" text-anchor="middle" fill="white" font-size="9">Siringoma/Idroadenoma</text>
                                <text x="550" y="442" text-anchor="middle" fill="white" font-size="8">‚ö†Ô∏è Correla con sede</text>
                            </g>
                            <line x1="760" y1="315" x2="800" y2="360" stroke="#dc3545" stroke-width="3" marker-end="url(#arrowhead)"/><text x="797" y="333" fill="#dc3545" font-weight="bold" font-size="10">NO</text>
                            <g>
                                <rect x="700" y="360" width="180" height="100" rx="10" fill="#ffd700" stroke="#ff8c00" stroke-width="2"/>
                                <text x="790" y="385" text-anchor="middle" font-weight="bold" font-size="11">CK7+ Ber-EP4‚àí?</text>
                                <text x="790" y="403" text-anchor="middle" font-size="9">+ infiltrazione profonda</text>
                                <text x="790" y="418" text-anchor="middle" font-size="9">+ desmoplasia</text>
                                <text x="790" y="435" text-anchor="middle" font-size="8" fill="#dc3545">‚õî BLOCCO su punch superficiale</text>
                            </g>
                            <line x1="790" y1="460" x2="790" y2="505" stroke="#dc3545" stroke-width="3" marker-end="url(#arrowhead)"/><text x="808" y="483" fill="#dc3545" font-weight="bold">S√å</text>
                            <g onclick="alert('üö® MAC sospetto!\nS100 per perineurale.\nMohs = GOLD STANDARD.\n‚õî NON diagnosticare su punch superficiale ‚Äî richiedere escissione profonda prima di diagnosi definitiva.')">
                                <rect x="700" y="505" width="180" height="125" rx="10" fill="#dc3545" stroke="#721c24" stroke-width="2"/>
                                <text x="790" y="533" text-anchor="middle" fill="white" font-weight="bold" font-size="16">MAC</text>
                                <text x="790" y="553" text-anchor="middle" fill="white" font-size="9">CK7+ Ber-EP4‚àí</text>
                                <text x="790" y="568" text-anchor="middle" fill="white" font-size="8">NO duttali ben definiti</text>
                                <text x="790" y="583" text-anchor="middle" fill="white" font-size="8">+ infiltrazione + desmoplasia</text>
                                <text x="790" y="600" text-anchor="middle" fill="white" font-size="8">S100 perineurale!</text>
                                <text x="790" y="617" text-anchor="middle" fill="white" font-size="8">Mohs surgery!</text>
                            </g>
                            <defs><marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto"><polygon points="0 0, 10 3, 0 6" fill="#333"/></marker></defs>
                        </svg>
                        <div class="alert alert-info" style="margin-top: 20px;"><strong>üí° Tip:</strong> Clicca sui box colorati per info rapide! v15.5: Ber-EP4 diffuso/focale distinto ‚Äî impatta DD BCC vs trichoepithelioma.</div>
                    </div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- MORFOLOGIA -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('morphology')">
                    <span>üìä MORFOLOGIA H&E ‚Äî Criteri Diagnostici</span>
                    <span class="toggle-icon" id="morphology-icon">‚ñº</span>
                </div>
                <div class="section-content" id="morphology-content">
                    <div class="checkbox-group">
                        <div class="checkbox-item"><input type="checkbox" id="palisade" name="morphology"><label for="palisade">Palizzata periferica nucleare <span class="badge badge-info">+3</span></label></div>
                        <div class="checkbox-item"><input type="checkbox" id="retraction" name="morphology"><label for="retraction">Retrazione stromale <span class="badge badge-secondary">+2</span> <span style="font-size:0.8em;color:#856404;">solo se con palizzata</span></label></div>
                        <div class="checkbox-item"><input type="checkbox" id="basaloid" name="morphology"><label for="basaloid">Cellule basaloidi (citoplasma scarso) <span class="badge badge-secondary">+2</span></label></div>
                        <div class="checkbox-item"><input type="checkbox" id="clefting" name="morphology"><label for="clefting">Spazi chiari peri-tumorali (clefting) <span class="badge badge-secondary">+2</span></label></div>
                        <div class="checkbox-item"><input type="checkbox" id="mucin" name="morphology"><label for="mucin">Stroma mucinoso</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="apoptosis" name="morphology"><label for="apoptosis">Corpi apoptotici</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="pigment" name="morphology"><label for="pigment">Pigmento melanico</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="papillary" name="morphology"><label for="papillary">Papille stromali fibrose (follicolare)</label></div>
                    </div>
                    <button onclick="analyzeMorphology()">Analizza Morfologia</button>
                    <button onclick="resetMorphology()">Reset</button>
                    <div class="disclaimer">‚ö†Ô∏è Score operativo (non validato formalmente). Palizzata √® il criterio trainante (+3); retrazione da sola ‚Äî senza palizzata ‚Äî √® artefatto non specifico e vale +2 solo in quel contesto. Clefting e basaloide sono supportivi.<br><strong>‚ö†Ô∏è Profondit√† infiltrativa non valutabile su biopsie superficiali/tangenziali ‚Äî rivalutare su campione con sottocute incluso.</strong></div>
                    <div id="morphology-result"></div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- IHC PANEL ‚Äî v15.5: Ber-EP4 diffuso/focale, CK5/6 integrato -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('ihc')">
                    <span>üß™ PANEL IHC ‚Äî Diagnosi Differenziale</span>
                    <span class="toggle-icon" id="ihc-icon">‚ñº</span>
                </div>
                <div class="section-content" id="ihc-content">

                    <div class="alert alert-info" style="margin-bottom:10px;">
                        <strong>v15.5 ‚Äî Novit√†:</strong> Ber-EP4 ora distingue <em>diffuso</em> vs <em>focale</em> (impatta DD BCC/trichoepithelioma). CK5/6 integrato nella logica. Avvocato del diavolo attivo su campioni superficiali.
                    </div>

                    <h4 style="color:#667eea;">Panel base ‚Äî basaloide/squamoide:</h4>
                    <div class="ihc-group-grid">
                        <!-- Ber-EP4: diffuso vs focale (FIX chiave v15.5) -->
                        <div class="ihc-row">
                            <input type="checkbox" id="berep4" name="ihc" style="width:20px;height:20px;margin-right:8px;">
                            <label for="berep4">Ber-EP4</label>
                            <select id="berep4-extent" style="padding:4px 8px;border-radius:5px;border:1px solid #ccc;font-size:0.85em;background:white;">
                                <option value="diffuse">diffuso (&gt;50%)</option>
                                <option value="focal">focale (&lt;50%)</option>
                            </select>
                        </div>
                        <div class="ihc-row"><input type="checkbox" id="p63" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="p63">p63 (diffuso nucleare)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="p40" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="p40">p40 (diffuso nucleare)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="ck56" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="ck56">CK5/6 (diffuso) ‚Äî squamoide/basaloide</label></div>
                        <div class="ihc-row"><input type="checkbox" id="bcl2" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="bcl2">Bcl-2 (diffuso)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="ema" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="ema">EMA (focale/duttale)</label></div>
                    </div>

                    <h4 style="color:#667eea;">Panel eccrina/MAC:</h4>
                    <div class="ihc-group-grid">
                        <div class="ihc-row"><input type="checkbox" id="ck7" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="ck7">CK7 (diffuso)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="cea" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="cea">CEA (duttale)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="s100" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="s100">S100 (perineurale ‚Äî MAC)</label></div>
                    </div>

                    <h4 style="color:#667eea;">Panel stromale/follicolare:</h4>
                    <div class="ihc-group-grid">
                        <div class="ihc-row"><input type="checkbox" id="cd10" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="cd10">CD10 (stromale)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="cd34" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="cd34">CD34 (stromale)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="ck20" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="ck20">CK20 (cellule di Merkel)</label></div>
                    </div>

                    <h4 style="color:#667eea;">Panel sebaceo/metastasi:</h4>
                    <div class="ihc-group-grid">
                        <div class="ihc-row"><input type="checkbox" id="androgen" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="androgen">Recettore androgenico (AR)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="adipophilin" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="adipophilin">Adipofilina (sebaceo ‚Äî specifico)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="gata3" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="gata3">GATA3 (mammella/uroteliale)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="ttf1" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="ttf1">TTF1 (polmone/tiroide)</label></div>
                        <div class="ihc-row"><input type="checkbox" id="cdx2" name="ihc" style="width:20px;height:20px;margin-right:8px;"><label for="cdx2">CDX2 (GI)</label></div>
                    </div>

                    <button onclick="analyzeIHC()">Analizza IHC</button>
                    <button onclick="resetIHC()">Reset</button>
                    <div id="ihc-result"></div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- VARIANTI BCC -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('variants')">
                    <span>‚ö†Ô∏è VARIANTI ISTOLOGICHE BCC</span>
                    <span class="toggle-icon" id="variants-icon">‚ñº</span>
                </div>
                <div class="section-content" id="variants-content">
                    <div class="alert alert-info"><strong>Seleziona la/le variante/i identificata/e:</strong></div>
                    <h4 style="color: #28a745;">‚úÖ VARIANTI A BASSO RISCHIO:</h4>
                    <div class="checkbox-group">
                        <div class="checkbox-item"><input type="checkbox" id="var-nodular" name="variant" onchange="updateVariantInfo()"><label for="var-nodular">Nodulare (60-80%)</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-cystic" name="variant" onchange="updateVariantInfo()"><label for="var-cystic">Nodulare-Cistico</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-superficial" name="variant" onchange="updateVariantInfo()"><label for="var-superficial">Superficiale/Multicentrico</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-infundibulo" name="variant" onchange="updateVariantInfo()"><label for="var-infundibulo">Infundibulo-Cistico</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-pinkus" name="variant" onchange="updateVariantInfo()"><label for="var-pinkus">Fibroepiteliale (Pinkus)</label></div>
                    </div>
                    <h4 style="color: #dc3545;">‚ö†Ô∏è VARIANTI AD ALTO RISCHIO (Aggressive):</h4>
                    <div class="checkbox-group">
                        <div class="checkbox-item"><input type="checkbox" id="var-infiltrative" name="variant" onchange="updateVariantInfo()"><label for="var-infiltrative">Infiltrativo</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-micronodular" name="variant" onchange="updateVariantInfo()"><label for="var-micronodular">Micronodulare ‚ö†Ô∏è DD/MAC</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-morphea" name="variant" onchange="updateVariantInfo()"><label for="var-morphea">Morpheiforme/Sclerosante</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-basosquamous" name="variant" onchange="updateVariantInfo()"><label for="var-basosquamous">Basosquamoso (Metatipico) ‚ö†Ô∏è</label></div>
                        <div class="checkbox-item"><input type="checkbox" id="var-mixed" name="variant" onchange="updateVariantInfo()"><label for="var-mixed">Misto (con componente aggressiva)</label></div>
                    </div>
                    <div id="variant-details"></div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- DD ECCRINE + MAC -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('eccrine')">
                    <span>üíß DD LESIONI POROMATOSE/ECCRINE vs MAC</span>
                    <span class="toggle-icon" id="eccrine-icon">‚ñº</span>
                </div>
                <div class="section-content" id="eccrine-content">
                    <div class="alert alert-danger"><strong>‚ö†Ô∏è RED FLAGS CRITICHE:</strong><br>
                    ‚Ä¢ Strutture duttali BEN DEFINITE + CK7+ + Ber-EP4‚àí = LESIONE ECCRINA<br>
                    ‚Ä¢ CK7+ + Ber-EP4‚àí + ASSENZA duttali ben definiti + infiltrazione profonda = MAC!<br>
                    <span style="font-size:0.9em; display:block; margin-top:6px;"><strong>‚ö†Ô∏è Sede:</strong> palmo/pianta ‚Üí poroma pi√π probabile; volto/labbro superiore ‚Üí MAC in DD.</span>
                    </div>
                    <table>
                        <thead><tr><th>Feature</th><th>BCC</th><th>Poroma</th><th>Idroadenoma</th><th>Spiroadenoma</th><th>Siringoma</th><th>MAC</th></tr></thead>
                        <tbody>
                            <tr><td><strong>Palizzata periferica</strong></td><td>‚úì‚úì</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td></tr>
                            <tr><td><strong>Retrazione stromale</strong></td><td>‚úì‚úì</td><td>‚àí</td><td>‚àí</td><td>+/‚àí</td><td>‚àí</td><td>‚àí</td></tr>
                            <tr><td><strong>Duttali BEN DEFINITI</strong></td><td>‚àí</td><td>‚úì</td><td>‚úì‚úì</td><td>‚úì‚úì</td><td>‚úì‚úì</td><td><mark>‚àí/+*</mark></td></tr>
                            <tr><td><strong>Microcisti + infiltrazione</strong></td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚úì‚úì</td></tr>
                            <tr><td><strong>Stroma desmoplastico</strong></td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚úì‚úì</td></tr>
                            <tr><td><strong>Invasione perineurale</strong></td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚úì (~50-70%)</td></tr>
                            <tr><td><strong>Cuticole</strong></td><td>‚àí</td><td>‚úì‚úì</td><td>‚àí</td><td>‚úì</td><td>‚àí</td><td>‚àí</td></tr>
                            <tr><td><strong>Ber-EP4</strong></td><td><span class="badge badge-success">‚úì‚úì diffuso</span></td><td><span class="badge badge-danger">‚àí</span></td><td><span class="badge badge-danger">‚àí</span></td><td><span class="badge badge-danger">‚àí</span></td><td><span class="badge badge-danger">‚àí</span></td><td><span class="badge badge-danger">‚àí</span></td></tr>
                            <tr><td><strong>CK7</strong></td><td>‚àí</td><td>‚úì</td><td>‚úì‚úì</td><td>‚úì‚úì</td><td>‚úì‚úì</td><td>‚úì‚úì</td></tr>
                            <tr><td><strong>CK5/6</strong></td><td>‚úì</td><td>‚úì‚úì</td><td>+/‚àí</td><td>+/‚àí</td><td>‚àí</td><td>‚àí/+</td></tr>
                            <tr><td><strong>CEA</strong></td><td>‚àí</td><td>‚úì</td><td>‚úì‚úì</td><td>‚úì</td><td>‚úì</td><td>‚úì (focale)</td></tr>
                            <tr><td><strong>p63 diffuso</strong></td><td>‚úì‚úì</td><td>‚àí</td><td>+/‚àí</td><td>+/‚àí</td><td>‚àí</td><td>+/‚àí (variabile)</td></tr>
                            <tr><td><strong>p40</strong></td><td>‚úì</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí/+ variabile</td></tr>
                            <tr><td><strong>S100 (perineurale)</strong></td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚àí</td><td>‚úì‚úì ESSENZIALE</td></tr>
                        </tbody>
                    </table>
                    <p class="disclaimer">* MAC pu√≤ avere pseudo-duttali/microcisti con aspetto duttiforme, ma sono <strong>mal definiti/incompleti</strong> (no cuticole, no lumi ben formati). Chiave: qualit√† morfologica, non solo presenza.</p>

                    <h3>üî¥ DD CRITICA: MAC vs BCC MICRONODULARE</h3>
                    <div class="alert alert-danger">
                        <strong>Entrambi hanno nidi piccoli infiltranti + stroma fibrotico ‚Äî facile confonderli!</strong>
                        <table style="width:100%; margin-top:10px; font-size:0.9em;">
                            <tr><th style="background:#dc3545; color:white; padding:8px;">Feature</th><th style="background:#dc3545; color:white; padding:8px;">BCC Micronodulare</th><th style="background:#dc3545; color:white; padding:8px;">MAC</th></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>Ber-EP4</strong></td><td style="padding:6px; border:1px solid #ddd; background:#d4edda;">‚úì‚úì POSITIVO (diffuso)</td><td style="padding:6px; border:1px solid #ddd; background:#f8d7da;">NEGATIVO</td></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>Palizzata periferica</strong></td><td style="padding:6px; border:1px solid #ddd;">Presente (anche se ridotta)</td><td style="padding:6px; border:1px solid #ddd;">Assente</td></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>Retrazione stromale</strong></td><td style="padding:6px; border:1px solid #ddd;">Presente</td><td style="padding:6px; border:1px solid #ddd;">Assente</td></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>CK7</strong></td><td style="padding:6px; border:1px solid #ddd; background:#f8d7da;">Negativo</td><td style="padding:6px; border:1px solid #ddd; background:#d4edda;">‚úì‚úì POSITIVO</td></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>CK5/6</strong></td><td style="padding:6px; border:1px solid #ddd;">‚úì (basaloide)</td><td style="padding:6px; border:1px solid #ddd;">‚àí/+ variabile</td></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>Microcisti cheratiniche</strong></td><td style="padding:6px; border:1px solid #ddd;">No</td><td style="padding:6px; border:1px solid #ddd;">S√¨</td></tr>
                            <tr><td style="padding:6px; border:1px solid #ddd;"><strong>Invasione perineurale</strong></td><td style="padding:6px; border:1px solid #ddd;">Rara</td><td style="padding:6px; border:1px solid #ddd;">~50-70% (S100!)</td></tr>
                        </table>
                        <p style="margin-top:10px;"><strong>Take home:</strong> Nidi piccoli infiltranti e dubbio ‚Üí <strong>Ber-EP4 + CK7 + CK5/6 obbligatori. S100 sempre.</strong></p>
                    </div>

                    <h3>‚ö†Ô∏è CORNER CASES ‚Äî DD ESTESA:</h3>
                    <div class="alert alert-secondary">
                        <ul>
                            <li><strong>Carcinoma sebaceo:</strong> AR+ (ma BCC √® AR+ nel 50-70%!), <mark>adipofilina+</mark> = discriminante reale, vacuoli lipidici. Muir-Torre in DD.</li>
                            <li><strong>Metastasi cutanea:</strong> CK7/CK20 pattern organo-specifico. GATA3 (mammella/uroteliale), TTF1 (polmone/tiroide), CDX2 (colon).</li>
                            <li><strong>Carcinoma basosquamoso:</strong> Ber-EP4+ focale, EMA+ focale, p40+ nelle aree squamoidi ‚Äî eterogeneit√† intratumorale, non catturabile da un pattern monolitico.</li>
                            <li><strong>Merkel:</strong> CK20 dot-like paranucleolare, sinaptofisina+, cromogranina+. Merkel CK20‚àí/TTF1‚àí esiste (~5-10%): escludere con imaging/anamnesi.</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- MAC EXPANDED -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('mac')">
                    <span>üö® CARCINOMA ANNESSIALE MICROCISTICO (MAC)</span>
                    <span class="toggle-icon" id="mac-icon">‚ñº</span>
                </div>
                <div class="section-content" id="mac-content">
                    <div class="alert alert-danger">
                        <strong>‚ö†Ô∏è "Il lupo travestito da agnello":</strong> Morfologia BLAND + infiltrazione PROFONDA + ASSENZA duttali BEN DEFINITI = MAC!<br>
                        <strong style="display:block; margin-top:8px;">‚õî Su punch superficiale: sospendere giudizio definitivo. Richiedere escissione/rebiopsia profonda prima di firmare la diagnosi.</strong>
                    </div>
                    <h3>üî¨ Features diagnostiche chiave:</h3>
                    <div class="variant-card high-risk">
                        <h4>Morfologia "a doppio livello":</h4>
                        <ul>
                            <li><strong>Derma superficiale:</strong> aspetto "rassicurante" (siringoma-like) ‚Äî TRAPPOLA!</li>
                            <li><strong>Derma profondo/sottocute:</strong> piccoli dotti e corde infiltranti</li>
                            <li><strong>Microcisti</strong> con materiale cheratinico ‚Äî aspetto innocente ma infiltrante</li>
                            <li><strong>Pseudo-duttali:</strong> possono esserci, ma sono <mark>mal definiti/incompleti</mark> (no cuticole, no lumi ben formati)</li>
                            <li><strong>Stroma desmoplastico</strong> prominente</li>
                            <li><strong>‚ö†Ô∏è Invasione perineurale (~50-70%)</strong> ‚Äî S100 sempre!</li>
                            <li><strong>Cellularit√† bassa, mitosi rare</strong> ‚Äî falsa rassicurazione</li>
                        </ul>
                    </div>
                    <h3>üß™ IHC per MAC:</h3>
                    <table>
                        <thead><tr><th>Marker</th><th>MAC</th><th>Note Critiche</th></tr></thead>
                        <tbody>
                            <tr><td><strong>CK7</strong></td><td><span class="badge badge-success">‚úì‚úì Diffuso</span></td><td>Marker chiave ‚Äî differenziazione eccrino-duttale infiltrante</td></tr>
                            <tr><td><strong>Ber-EP4</strong></td><td><span class="badge badge-danger">‚ö†Ô∏è NEGATIVO</span></td><td>Discrimina da BCC ‚Äî se Ber-EP4+ diffuso ‚Üí NON √® MAC</td></tr>
                            <tr><td><strong>CK5/6</strong></td><td><span class="badge badge-warning">‚àí/+ variabile</span></td><td>Spesso + nelle componenti squamoidi superficiali. <strong>Non discriminante da BCC infiltrativo</strong> ‚Äî non usarlo per DD MAC/BCC.</td></tr>
                            <tr><td><strong>CEA</strong></td><td><span class="badge badge-warning">‚úì focale</span></td><td>Meno diffuso che in poroma/spiroadenoma</td></tr>
                            <tr><td><strong>p63</strong></td><td><span class="badge badge-warning">‚úì variabile (spesso +)</span></td><td>Frequentemente positivo ‚Äî <strong>non ha valore discriminante negativo</strong>. p63‚àí in MAC non esclude la diagnosi.</td></tr>
                            <tr><td><strong>Ki67</strong></td><td><span class="badge badge-info">&lt;10%</span></td><td>Basso ‚Äî contrasta con aspetto infiltrativo (trabocco!)</td></tr>
                            <tr><td><strong>S100</strong></td><td><span class="badge badge-danger">‚úì‚úì ESSENZIALE</span></td><td>Evidenzia invasione perineurale (~50-70% dei casi)</td></tr>
                        </tbody>
                    </table>
                    <h3>‚ö†Ô∏è Management:</h3>
                    <div class="result-box danger">
                        <strong>Recidiva locale: 40-60% se margini inadeguati</strong><br><br>
                        <ul>
                            <li><strong>Mohs surgery = GOLD STANDARD ‚Äî sempre preferita quando disponibile</strong></li>
                            <li><strong>Margini convenzionali ‚â•10mm:</strong> solo se Mohs non disponibile o non fattibile (recidiva comunque 15-20%)</li>
                            <li><strong>Follow-up:</strong> ogni 3-6 mesi √ó 5 anni</li>
                            <li><strong>Imaging pre-op se:</strong> invasione profonda/perineurale, zona H, >2cm</li>
                        </ul>
                    </div>
                    <h3>üö® PITFALLS COMUNI:</h3>
                    <div class="alert alert-warning">
                        <ol>
                            <li><strong>Biopsia superficiale:</strong> aspetto benigno misconosciuto</li>
                            <li><strong>Bassa cellularit√† + mitosi rare:</strong> falso senso di benignit√†</li>
                            <li><strong>Confondere con siringoma:</strong> MAC simula siringoma superficialmente</li>
                            <li><strong>Pseudo-duttali interpretati come veri:</strong> verificare qualit√† (cuticole? lumi formati?)</li>
                            <li><strong>Non richiedere S100:</strong> miss invasione perineurale = miss prognostico</li>
                            <li><strong>Margini inadeguati:</strong> recidive anche dopo Mohs parziale</li>
                            <li><strong>Non richiedere CK7+Ber-EP4 panel:</strong> diagnosi ritardata</li>
                        </ol>
                    </div>
                </div>
            </div>

            <!-- ============================================================ -->
            <!-- BIBLIOGRAFIA -->
            <!-- ============================================================ -->
            <div class="section">
                <div class="section-header" onclick="toggleSection('bibliography')">
                    <span>üìö BIBLIOGRAFIA EVIDENCE-BASED</span>
                    <span class="toggle-icon" id="bibliography-icon">‚ñº</span>
                </div>
                <div class="section-content" id="bibliography-content">
                    <div style="font-size: 0.9em; line-height: 1.8;">
                        <h3>üî¨ Morfologia & Istologia BCC:</h3>
                        <ol>
                            <li><strong>Sexton M, Jones DB, Maloney ME.</strong> Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. <em>J Am Acad Dermatol</em> 1990;23:1118-1126. <a href="https://doi.org/10.1016/0190-9622(90)70344-h" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/2273112/" target="_blank" class="bib-link">PMID: 2273112</a></li>
                            <li><strong>Crowson AN.</strong> Basal cell carcinoma: biology, morphology and clinical implications. <em>Mod Pathol</em> 2006;19:S127-S147. ‚≠ê <a href="https://doi.org/10.1038/modpathol.3800512" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/16446711/" target="_blank" class="bib-link">PMID: 16446711</a></li>
                        </ol>
                        <div class="disclaimer" style="margin:5px 0 15px 0;">
                            ‚ö†Ô∏è <strong>Nota v15.5 ‚Äî Ref. Rowe 1992 rimossa da questa sezione.</strong> Rowe DE et al. <em>J Am Acad Dermatol</em> 1992 riguarda i fattori prognostici dell'SCC, non del BCC. Era fuori contesto nella sezione morfologia BCC. Rimane disponibile come riferimento per la DD basosquamosa se necessario.
                        </div>
                        <h3>üß™ Immunoistochimica:</h3>
                        <ol start="3">
                            <li><strong>Kanitakis J.</strong> Anatomy, histology and immunohistochemistry of normal human skin. <em>Eur J Dermatol</em> 2002;12:390-401. <a href="https://pubmed.ncbi.nlm.nih.gov/12095893/" target="_blank" class="bib-link">PMID: 12095893</a></li>
                            <li><strong>Jih DM, Lyle S, Elenitsas R, et al.</strong> Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. <em>J Cutan Pathol</em> 1999;26:113-118. <a href="https://doi.org/10.1111/j.1600-0560.1999.tb01814.x" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/10235378/" target="_blank" class="bib-link">PMID: 10235378</a></li>
                            <li><strong>Poblet E, Jim√©nez-Acosta F, Rocamora A.</strong> QBEND/10 (anti-CD34 antibody) in external root sheath cells and basal cell carcinoma. <em>J Cutan Pathol</em> 1994;21:224-228. <a href="https://doi.org/10.1111/j.1600-0560.1994.tb00269.x" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/7521506/" target="_blank" class="bib-link">PMID: 7521506</a></li>
                            <li><strong>Beer TW, Shepherd P, Theaker JM.</strong> Ber-EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. <em>Histopathology</em> 2000;37:218-223. ‚≠ê <a href="https://doi.org/10.1046/j.1365-2559.2000.00999.x" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/10971697/" target="_blank" class="bib-link">PMID: 10971697</a></li>
                        </ol>
                        <h3>‚ö†Ô∏è Varianti BCC & Management:</h3>
                        <ol start="7">
                            <li><strong>NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer.</strong> Version 1.2024. ‚≠ê‚≠ê <a href="https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1416" target="_blank" class="bib-link">Link NCCN</a></li>
                            <li><strong>Bichakjian CK et al.</strong> Basal Cell Skin Cancer, Version 1.2016. <em>J Natl Compr Canc Netw</em> 2016;14:574-597. <a href="https://doi.org/10.6004/jnccn.2016.0065" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/27160235/" target="_blank" class="bib-link">PMID: 27160235</a></li>
                            <li><strong>Leibovitch I et al.</strong> Basal cell carcinoma treated with Mohs surgery in Australia II. <em>J Am Acad Dermatol</em> 2005;53:452-457. <a href="https://doi.org/10.1016/j.jaad.2005.04.087" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/16112352/" target="_blank" class="bib-link">PMID: 16112352</a></li>
                        </ol>
                        <h3>üîÑ DD Tricoblastoma/Trichoepithelioma:</h3>
                        <ol start="10">
                            <li><strong>Brooke JD.</strong> Epithelioma adenoides cysticum. <em>Br J Dermatol</em> 1892;4:269-287. <a href="https://doi.org/10.1111/j.1365-2133.1892.tb15899.x" target="_blank" class="bib-link">DOI</a></li>
                            <li><strong>Schulz T, Hartschuh W.</strong> Folliculo-sebaceous cystic hamartoma. <em>J Cutan Pathol</em> 1998;25:354-364. <a href="https://doi.org/10.1111/j.1600-0560.1998.tb01739.x" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/9740553/" target="_blank" class="bib-link">PMID: 9740553</a></li>
                            <li><strong>Misago N et al.</strong> Basal cell carcinoma with ductal and glandular differentiation. <em>Am J Dermatopathol</em> 2004;26:374-382. <a href="https://doi.org/10.1097/00000372-200410000-00003" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/15365365/" target="_blank" class="bib-link">PMID: 15365365</a></li>
                        </ol>
                        <h3>üíß Lesioni Eccrine/Poromatose:</h3>
                        <ol start="13">
                            <li><strong>Berman A, Winkelmann RK.</strong> Porocarcinoma and syringoid eccrine carcinoma. <em>Arch Dermatol</em> 1982;118:250-251. <a href="https://doi.org/10.1001/archderm.1982.01650160040015" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/7065653/" target="_blank" class="bib-link">PMID: 7065653</a></li>
                            <li><strong>Plaza JA et al.</strong> Value of p63 and podoplanin (D2-40). <em>Am J Dermatopathol</em> 2011;33:334-341. <a href="https://doi.org/10.1097/DAD.0b013e3181f92a0f" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/20520556/" target="_blank" class="bib-link">PMID: 20520556</a></li>
                            <li><strong>Minagawa A, Koga H.</strong> Diagnostic immunohistochemistry for cutaneous adnexal tumors. <em>J Dermatol</em> 2014;41:305-314. <a href="https://doi.org/10.1111/1346-8138.12367" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/24635013/" target="_blank" class="bib-link">PMID: 24635013</a></li>
                            <li><strong>Ivan D et al.</strong> Expression of p63 in primary cutaneous adnexal neoplasms. <em>Mod Pathol</em> 2005;18:137-142. <a href="https://doi.org/10.1038/modpathol.3800270" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/15467711/" target="_blank" class="bib-link">PMID: 15467711</a></li>
                        </ol>
                        <h3>üö® Carcinoma Annessiale Microcistico (MAC):</h3>
                        <ol start="17">
                            <li><strong>Goldstein DJ, Barr RJ, Santa Cruz DJ.</strong> Microcystic adnexal carcinoma: a distinct clinicopathologic entity. <em>Cancer</em> 1982;50:566-572. ‚≠ê <a href="https://doi.org/10.1002/1097-0142(19820801)50:3<566::aid-cncr2820500330>3.0.co;2-q" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/7093897/" target="_blank" class="bib-link">PMID: 7093897</a></li>
                            <li><strong>Chiller K et al.</strong> Microcystic adnexal carcinoma: forty-eight cases. <em>Arch Dermatol</em> 2000;136:1355-1359. <a href="https://doi.org/10.1001/archderm.136.11.1355" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/11074699/" target="_blank" class="bib-link">PMID: 11074699</a></li>
                            <li><strong>Leibovitch I et al.</strong> Microcystic adnexal carcinoma: treatment with Mohs. <em>J Am Acad Dermatol</em> 2005;52:295-300. ‚≠ê <a href="https://doi.org/10.1016/j.jaad.2004.10.868" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/15692477/" target="_blank" class="bib-link">PMID: 15692477</a></li>
                            <li><strong>Zalla MJ et al.</strong> Microcystic adnexal carcinoma: a Mohs series. <em>Dermatol Surg</em> 2005;31:1386-1391. <a href="https://doi.org/10.1111/j.1524-4725.2005.31230" target="_blank" class="bib-link">DOI</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/16188198/" target="_blank" class="bib-link">PMID: 16188198</a></li>
                        </ol>
                        <div class="alert alert-info" style="margin-top: 20px;">
                            <strong>üí°</strong> DOI e PMID garantiscono accesso permanente. Totale referenze v15.5: 20 (rimossa ref. Rowe 1992 fuori contesto).
                        </div>
                    </div>
                </div>
            </div>

        </div><!-- end .content -->

        <footer>
            <p>üî¨ Tool Diagnostico Lesioni Basaloidi v15.5</p>
            <p>Evidence-Based ‚Ä¢ 2026 ‚Ä¢ <a href="https://github.com/Infingardo" target="_blank">@Infingardo</a></p>
            <p style="font-size: 0.8em; margin-top: 10px; opacity: 0.8;">Per uso educazionale. Non sostituisce il giudizio clinico-morfologico.</p>
        </footer>
    </div><!-- end .container -->

    <!-- ================================================================== -->
    <!-- JAVASCRIPT -->
    <!-- ================================================================== -->
    <script>

    // ---- TOGGLE SECTIONS ----
    function toggleSection(id) {
        const content = document.getElementById(id + '-content');
        const icon = document.getElementById(id + '-icon');
        if (content && icon) {
            content.classList.toggle('active');
            icon.classList.toggle('rotated');
        }
    }

    // ---- CLINICAL WARNINGS ----
    function isSuperFicialBiopsy() {
        const biopsy = document.getElementById('clinical-biopsy')?.value || '';
        return biopsy === 'punch-superficial';
    }

    function updateClinicalWarnings() {
        const site = document.getElementById('clinical-site')?.value || '';
        const biopsy = document.getElementById('clinical-biopsy')?.value || '';
        const recurrence = document.getElementById('clinical-recurrence')?.checked || false;
        const immunosupp = document.getElementById('clinical-immunosupp')?.checked || false;
        const warnings = [];

        if (site === 'h-zone')
            warnings.push('<span class="badge badge-danger">Zona H</span> Margini ‚â•6mm o Mohs per qualsiasi BCC in questa sede. <strong>‚ö†Ô∏è In zona H: se CK7+/Ber-EP4‚àí, sospetto MAC deve salire di livello ‚Äî sede tipica di MAC aggressivo.</strong>');
        if (site === 'palmoplantar')
            warnings.push('<span class="badge badge-info">Palmo/Pianta</span> BCC raro. Sede tipica per poroma eccrina ‚Äî tenerla in DD.');
        if (biopsy === 'punch-superficial')
            warnings.push('<span class="badge badge-warning">Biopsia superficiale ‚ö†Ô∏è</span> MAC e varianti infiltrative possono essere misconosciute. Score morfologico sottostimato. <strong>Analisi IHC MAC bloccata</strong> finch√© non disponibile escissione profonda.');
        if (recurrence)
            warnings.push('<span class="badge badge-danger">Recidiva</span> Sospettare variante aggressiva misconosciuta. Mohs fortemente raccomandato.');
        if (immunosupp)
            warnings.push('<span class="badge badge-danger">Immunosoppresso</span> Rischio aumentato BCC aggressivo, SCC, Merkel. Follow-up intensivo.');

        const warningDiv = document.getElementById('clinical-warnings');
        if (warnings.length > 0)
            warningDiv.innerHTML = '<div class="result-box warning" style="margin-top:15px;"><h4>‚ö†Ô∏è Alert clinici:</h4><ul>' + warnings.map(w => '<li>' + w + '</li>').join('') + '</ul></div>';
        else
            warningDiv.innerHTML = '';
    }

    // ---- MORFOLOGIA ----
    function analyzeMorphology() {
        const palisade = document.getElementById('palisade').checked;
        const retraction = document.getElementById('retraction').checked;
        const basaloid = document.getElementById('basaloid').checked;
        const clefting = document.getElementById('clefting').checked;
        const score = (palisade ? 3 : 0) + (retraction ? 2 : 0) + (basaloid ? 2 : 0) + (clefting ? 2 : 0);
        // Avvocato del diavolo: retrazione senza palizzata
        const retractionWithoutPalisade = retraction && !palisade;
        const resultDiv = document.getElementById('morphology-result');
        const superficial = isSuperFicialBiopsy();
        const retractionNote = retractionWithoutPalisade ? '<p class="disclaimer" style="margin-top:8px;"><strong>‚ö†Ô∏è Retrazione senza palizzata:</strong> non √® specifica per BCC ‚Äî pu√≤ essere artefatto da fissazione in qualsiasi lesione cutanea. Peso ridotto a +2 in assenza di palizzata.</p>' : '';
        const superficialNote = superficial ? '<p class="disclaimer" style="margin-top:8px;"><strong>‚ö†Ô∏è Biopsia superficiale:</strong> profondit√† infiltrativa non valutabile ‚Äî rivalutare su campione con sottocute incluso.</p>' : '';

        if (score >= 6)
            resultDiv.innerHTML = `<div class="result-box success"><h3>‚úÖ PATTERN BCC-LIKE (alta probabilit√†)</h3><p><strong>Score: ${score}/9</strong></p><p>Confermare con Ber-EP4 diffuso + p63. Se piccola/simmetrica: DD trichoepithelioma. Se EMA+ focale: DD basosquamoso.</p>${retractionNote}${superficialNote}</div>`;
        else if (score >= 3)
            resultDiv.innerHTML = `<div class="result-box warning"><h3>‚ö†Ô∏è PATTERN BASALOIDE INDETERMINATO</h3><p><strong>Score: ${score}/9</strong></p><p>DD: Tricoblastoma, lesioni eccrine, MAC, basosquamoso. Panel IHC raccomandato.</p>${retractionNote}${superficialNote}</div>`;
        else
            resultDiv.innerHTML = `<div class="result-box danger"><h3>‚ùå PATTERN NON BCC-LIKE</h3><p><strong>Score: ${score}/9</strong></p><p>Valutare: lesioni eccrine, MAC, metastasi, sebaceo. Panel IHC esteso.</p>${retractionNote}${superficialNote}</div>`;
    }

    function resetMorphology() {
        document.querySelectorAll('input[name="morphology"]').forEach(cb => cb.checked = false);
        document.getElementById('morphology-result').innerHTML = '';
    }

    // ---- IHC ANALYSIS ‚Äî v15.5 ----
    function analyzeIHC() {
        // raccolta valori
        const berep4     = document.getElementById('berep4').checked;
        const berep4ext  = document.getElementById('berep4-extent').value; // 'diffuse' | 'focal'
        const p63        = document.getElementById('p63').checked;
        const p40        = document.getElementById('p40').checked;
        const ck56       = document.getElementById('ck56').checked;
        const bcl2       = document.getElementById('bcl2').checked;
        const ema        = document.getElementById('ema').checked;
        const ck7        = document.getElementById('ck7').checked;
        const cea        = document.getElementById('cea').checked;
        const s100       = document.getElementById('s100').checked;
        const cd10       = document.getElementById('cd10').checked;
        const cd34       = document.getElementById('cd34').checked;
        const ck20       = document.getElementById('ck20').checked;
        const androgen   = document.getElementById('androgen').checked;
        const adipophilin= document.getElementById('adipophilin').checked;
        const gata3      = document.getElementById('gata3').checked;
        const ttf1       = document.getElementById('ttf1').checked;
        const cdx2       = document.getElementById('cdx2').checked;
        const superficial= isSuperFicialBiopsy();

        const resultDiv  = document.getElementById('ihc-result');

        // --- SEBACEOUS: adipofilina √® discriminante definitivo ---
        if (adipophilin) {
            resultDiv.innerHTML = `<div class="result-box danger">
                <h3>üü° ADIPOFILINA+ : CARCINOMA SEBACEO PROBABILE</h3>
                <p>Vacuoli lipidici + adipofilina+ = differenziazione sebacea. Confermare con EMA membranoso e morfologia.</p>
                ${androgen ? '<p><span class="badge badge-success">AR+</span> supporta la diagnosi</p>' : ''}
                <p><strong>‚ö†Ô∏è Considerare sindrome di Muir-Torre:</strong> richiedere IHC MMR (MLH1/MSH2/MSH6/PMS2).</p>
            </div>`;
            return;
        }

        // --- AR+ da solo: NON conclusivo ---
        if (androgen && !adipophilin && !ck7 && !gata3 && !ttf1 && !cdx2) {
            const msg = berep4
                ? `<div class="result-box warning"><h3>‚ö†Ô∏è AR+ CON Ber-EP4+ : NON CONCLUSIVO PER SEBACEO</h3>
                   <p>BCC √® AR+ nel 50-70%. AR+ non discrimina in presenza di Ber-EP4+.</p>
                   <p><strong>Se sospetto sebaceo:</strong> richiedere <mark>Adipofilina</mark> (specifico) + cercare vacuoli lipidici alla morfologia.</p></div>`
                : `<div class="result-box warning"><h3>‚ö†Ô∏è AR+ SENZA Ber-EP4 : SOSPETTO SEBACEO</h3>
                   <p>AR+ senza Ber-EP4 aumenta il sospetto. <strong>Richiedere Adipofilina per conferma definitiva.</strong></p></div>`;
            resultDiv.innerHTML = msg;
            return;
        }

        // --- METASTASI ---
        if (gata3 || ttf1 || cdx2) {
            const origin = [];
            if (gata3) origin.push('mammella/uroteliale (GATA3)');
            if (ttf1)  origin.push('polmone/tiroide (TTF1)');
            if (cdx2)  origin.push('GI/colon-retto (CDX2)');
            resultDiv.innerHTML = `<div class="result-box danger">
                <h3>üî¥ PATTERN SUGGESTIVO PER METASTASI CUTANEA</h3>
                <p>Marker organo-specifici: <strong>${origin.join(', ')}</strong>.</p>
                <p>Profilo non compatibile con neoplasia cutanea primitiva. Staging sistemico + correlazione anamnesi oncologica.</p>
            </div>`;
            return;
        }

        // --- MERKEL ---
        if (ck20) {
            resultDiv.innerHTML = `<div class="result-box danger">
                <h3>üî¥ CK20+ : ALTAMENTE SUGGESTIVO PER CARCINOMA A CELLULE DI MERKEL</h3>
                <p><strong>Pattern dot-like paranucleolare</strong>. Confermare con: Sinaptofisina, Cromogranina, CD56.</p>
                <p class="disclaimer">‚ö†Ô∏è Merkel CK20‚àí/TTF1‚àí esiste (~5-10%). Metastasi neuroendocrine (SCLC, carcinoide) possono mimare ‚Äî escludere con imaging/anamnesi.</p>
            </div>`;
            return;
        }

        // --- PATTERN IBRIDO Ber-EP4+/CK7+ (insolito) ---
        if (berep4 && ck7) {
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è PATTERN IBRIDO: Ber-EP4+ / CK7+</h3>
                <p>Combinazione insolita. Considerare:</p>
                <ul>
                    <li>BCC con differenziazione eccrina focale (raro, descritto in letteratura)</li>
                    <li>Artefatto/clone anticorpale ‚Äî verificare intensit√† e distribuzione con patologo senior</li>
                    <li>Ripetere IHC su sezioni diverse</li>
                </ul>
                <p>Correlare strettamente con morfologia. Se dubbio persiste: second opinion.</p>
            </div>`;
            return;
        }

        // --- MAC: safeguard ATTIVO su biopsia superficiale ---
        const isMACcandidate = ck7 && !berep4 && !cea;
        if (isMACcandidate && superficial) {
            resultDiv.innerHTML = `<div class="result-box blocked">
                <h3>‚õî ANALISI MAC SOSPESA ‚Äî CAMPIONE INADEGUATO</h3>
                <p><strong>CK7+ Ber-EP4‚àí su punch superficiale = pattern compatibile con MAC ma NON diagnostico.</strong></p>
                <p>MAC si manifesta solo in profondit√† (derma profondo/sottocute). Un punch superficiale cattura solo la porzione benigna apparente ("siringoma-like").</p>
                <p><strong>Azioni richieste prima di concludere:</strong></p>
                <ul>
                    <li>Richiedere escissione ampia o rebiopsia profonda con sottocute incluso</li>
                    <li>Valutare invasione perineurale su sezioni seriali (S100)</li>
                    <li>Morfologia: cercare microcisti + desmoplasia profonda</li>
                </ul>
                <p class="disclaimer">Emettere referto con diagnosi sospesa e raccomandazione esplicita di rebiopsia profonda.</p>
            </div>`;
            return;
        }

        // --- MAC su campione adeguato ---
        if (isMACcandidate) {
            const s100note = s100 ? '<p><span class="badge badge-danger">S100+</span> Invasione perineurale documentata ‚Äî indicazione assoluta a Mohs.</p>' : '<p><strong>‚ö†Ô∏è S100 non richiesto o non specificato.</strong> Richiedere per valutare invasione perineurale.</p>';
            resultDiv.innerHTML = `<div class="result-box danger">
                <h3>üö® CK7+ BER-EP4‚àí (no CEA) = MAC CANDIDATO</h3>
                <p>Pattern IHC compatibile con MAC. Confermare su morfologia:</p>
                <ul>
                    <li>Infiltrazione profonda (derma profondo/sottocute)</li>
                    <li>Stroma desmoplastico</li>
                    <li>Microcisti cheratiniche</li>
                    <li>Assenza duttali ben definiti (cuticole, lumi formati)</li>
                </ul>
                ${s100note}
                <p class="disclaimer">Se mancano i criteri morfologici: non concludere MAC ‚Äî rivalutare.</p>
            </div>`;
            return;
        }

        // --- CK7+/CEA+ ‚Üí eccrina o MAC ---
        if (ck7 && cea && !berep4) {
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è CK7+ / CEA+ / Ber-EP4‚àí : ECCRINA vs MAC</h3>
                <p><strong>Se duttali BEN DEFINITI alla morfologia:</strong> Lesione eccrina (Poroma/Spiroadenoma/Siringoma/Idroadenoma).</p>
                <p><strong>Se duttali assenti o mal definiti + infiltrazione profonda:</strong> Considerare MAC ‚Äî CEA pu√≤ essere focale in MAC.</p>
            </div>`;
            return;
        }

        // --- BCC CLASSICO Ber-EP4 diffuso ---
        if (berep4 && berep4ext === 'diffuse' && p63 && !ck7 && !ema) {
            let extras = '';
            if (bcl2) extras += '<p><span class="badge badge-info">Bcl-2+</span> supporta la diagnosi.</p>';
            if (ck56) extras += '<p><span class="badge badge-info">CK5/6+</span> compatibile con BCC (√® un carcinoma basaloide CK5/6+). Non discriminante da solo.</p>';
            resultDiv.innerHTML = `<div class="result-box success">
                <h3>‚úÖ PATTERN FORTEMENTE SUGGESTIVO PER BCC</h3>
                <p><strong>Ber-EP4 diffuso / p63+ diffuso</strong></p>
                ${extras}
                <p class="disclaimer">‚ö†Ô∏è Se lesione piccola, simmetrica, con papille stromali e stroma CD10+/CD34+: non escludere trichoepithelioma (DD follicolare).</p>
            </div>`;
            return;
        }

        // --- Ber-EP4 FOCALE: BCC vs Trichoepithelioma ‚Äî con ramo infiltrativo (v15.6) ---
        if (berep4 && berep4ext === 'focal' && p63) {
            const follicular = (cd10 || cd34);
            // BCC infiltrativo/micronodulare pu√≤ perdere Ber-EP4 nelle aree profonde
            // Se variante aggressiva selezionata e CK7‚àí: BCC rimane pi√π probabile, non spingere verso follicolare
            const morphInfiltrative = document.getElementById('var-infiltrative')?.checked || document.getElementById('var-micronodular')?.checked || false;
            if (morphInfiltrative && !ck7) {
                resultDiv.innerHTML = `<div class="result-box warning">
                    <h3>‚ö†Ô∏è Ber-EP4 FOCALE + PATTERN INFILTRATIVO + CK7‚àí</h3>
                    <p><strong>BCC infiltrativo rimane probabile ‚Äî non virare verso follicolare.</strong></p>
                    <p>BCC infiltrativi/micronodulari possono perdere parzialmente Ber-EP4 nelle aree profonde. CK7 negativo depone contro MAC o lesione eccrina.</p>
                    <ul>
                        <li>Ber-EP4 almeno focale (vs MAC dove √® assente)</li>
                        <li>CK7‚àí (MAC √® CK7+ diffuso)</li>
                        <li>Cercare palizzata residua anche se ridotta nelle aree superficiali</li>
                    </ul>
                    <p class="disclaimer">DD follicolare meno probabile in assenza di simmetria e stroma CD10+/CD34+.</p>
                </div>`;
                return;
            }
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è Ber-EP4 FOCALE + p63+ : BCC vs TRICHOEPITHELIOMA</h3>
                <p>Ber-EP4 focale (&lt;50%) NON √® diagnostico di BCC ‚Äî si riscontra anche in trichoepitheliomi.</p>
                <p><strong>Valutare:</strong></p>
                <ul>
                    <li>Simmetria della lesione e architettura (trichoepithelioma √® ben circoscritto)</li>
                    <li>Papille stromali fibrose (follicolare)</li>
                    ${follicular ? '<li><span class="badge badge-success">Stroma CD10/CD34+</span> ‚Üí orienta verso <strong>TRICHOEPITHELIOMA</strong></li>' : '<li>CD10/CD34 stromale non specificato ‚Äî richiedere per DD follicolare</li>'}
                    <li>CK15 (se disponibile) ‚Äî positivo in trichoepithelioma</li>
                </ul>
                <p class="disclaimer">In assenza di simmetria e stroma follicolare, BCC rimane pi√π probabile anche con Ber-EP4 focale.</p>
            </div>`;
            return;
        }

        // --- BASOSQUAMOSO ---
        if (berep4 && p63 && p40 && ema) {
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è PATTERN SUGGESTIVO PER CARCINOMA BASOSQUAMOSO</h3>
                <p><strong>Ber-EP4+ / p63+ / p40+ / EMA+ focale</strong></p>
                <p>Features basaloidi + squamoidi. <strong>Variante aggressiva ‚Äî margini ‚â•6mm o Mohs.</strong></p>
                <p class="disclaimer">Nota: p40 e EMA tipicamente positivi nelle aree squamoidi (eterogeneit√† intratumorale). Mappare le aree su sezioni multiple. Ref: Beer 2000, Histopathology.</p>
            </div>`;
            return;
        }

        // --- BCC con EMA focale ---
        if (berep4 && p63 && ema && !ck7 && !p40) {
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è BCC CON EMA+ FOCALE: VALUTARE BASOSQUAMOSO</h3>
                <p>EMA focale in contesto Ber-EP4+ suggerisce possibile differenziazione squamoide.</p>
                <p><strong>Richiedere p40:</strong> se p40+ diffuso nelle aree EMA+ ‚Üí carcinoma basosquamoso.</p>
            </div>`;
            return;
        }

        // --- CK5/6 positivo da solo o con p63 (senza Ber-EP4) ---
        if (ck56 && !berep4 && p63 && !ck7 && !cd10 && !cd34) {
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è CK5/6+ / p63+ / Ber-EP4‚àí : CARCINOMA SQUAMOCELLULARE in DD</h3>
                <p>Profilo squamoide (CK5/6+ diffuso + p63+) senza Ber-EP4.</p>
                <p><strong>Considerare:</strong></p>
                <ul>
                    <li>Carcinoma squamocellulare cutaneo (SCC)</li>
                    <li>SCC poco differenziato / basaloide</li>
                    <li>Metastasi cutanea da SCC testa-collo (EMA, p16 HPV se sospetto)</li>
                </ul>
                <p>Correlazione morfologica essenziale: cercare ponti intercellulari, cheratinizzazione.</p>
            </div>`;
            return;
        }

        // --- FOLLICOLARE CD10/CD34 ---
        if ((cd10 || cd34) && !berep4 && !ck7) {
            resultDiv.innerHTML = `<div class="result-box warning">
                <h3>‚ö†Ô∏è STROMA CD10/CD34+ : LESIONE FOLLICOLARE</h3>
                <p>Pattern compatibile con tricoblastoma/trichoepithelioma.</p>
                <p><strong>Confermare con morfologia:</strong> simmetria, papille stromali, assenza retrazione artefattuale.</p>
                <p class="disclaimer">‚ö†Ô∏è Ber-EP4 pu√≤ essere focalmente+ in alcuni trichoepitheliomi ‚Äî intensit√† e distribuzione contano.</p>
            </div>`;
            return;
        }

        // --- DEFAULT non conclusivo ---
        resultDiv.innerHTML = `<div class="result-box">
            <h3>üìä PATTERN IHC NON CONCLUSIVO ‚Äî ESTENDERE PANEL</h3>
            <p>Profilo atipico o incompleto. Suggerire:</p>
            <ul>
                <li><strong>Adipofilina, EMA, AR:</strong> carcinoma sebaceo</li>
                <li><strong>GATA3, TTF1, CDX2:</strong> metastasi cutanea</li>
                <li><strong>CK5/6:</strong> conferma differenziazione squamoide</li>
                <li><strong>SOX10, S100:</strong> melanocitario/perineurale</li>
            </ul>
        </div>`;
    }

    function resetIHC() {
        document.querySelectorAll('input[name="ihc"]').forEach(cb => cb.checked = false);
        document.getElementById('berep4-extent').value = 'diffuse';
        document.getElementById('ihc-result').innerHTML = '';
    }

    // ---- VARIANTI BCC ----
    function updateVariantInfo() {
        const variants = {
            'var-nodular':       { name: 'BCC Nodulare', risk: 'low',  desc: 'Variante pi√π comune (60-80%). Nidi basaloidi con palizzata classica.', margins: '4mm (>95% clearance)', recurrence: '<5%', mohs: 'Non necessaria per lesioni <2cm in zone non-H' },
            'var-cystic':        { name: 'BCC Nodulare-Cistico', risk: 'low', desc: 'Degenerazione cistica centrale. Comportamento identico al nodulare.', margins: '4mm', recurrence: '<5%', mohs: 'Non necessaria' },
            'var-superficial':   { name: 'BCC Superficiale/Multicentrico', risk: 'low', desc: 'Nidi multipli superficiali connessi all\'epidermide. Tipico del tronco.', margins: '4-5mm', recurrence: '5-10%', mohs: 'Non necessaria se margini adeguati' },
            'var-infundibulo':   { name: 'BCC Infundibulo-Cistico', risk: 'low', desc: 'Raro. Cisti infundibulari con palizzata. Prognosi eccellente.', margins: '4mm', recurrence: '<5%', mohs: 'Non necessaria' },
            'var-pinkus':        { name: 'BCC Fibroepiteliale (Pinkus)', risk: 'low', desc: 'Cordoni anastomizzanti in stroma fibroso. Indolente.', margins: '4mm', recurrence: '<5%', mohs: 'Non necessaria' },
            'var-infiltrative':  { name: 'BCC Infiltrativo', risk: 'high', desc: 'Cordoni irregolari infiltranti in profondit√†. Margini clinicamente mal definiti.', margins: '‚â•6mm (Mohs preferita)', recurrence: '20-25%', mohs: '‚úì‚úì FORTEMENTE RACCOMANDATA' },
            'var-micronodular':  { name: 'BCC Micronodulare', risk: 'high', desc: 'Nidi piccoli (<0.15mm) oltre margini apparenti. ‚ö†Ô∏è DD critica con MAC: entrambi hanno nidi piccoli + stroma. Chiave: Ber-EP4 diffuso (BCC), CK7 (MAC), palizzata (BCC), microcisti (MAC).', margins: '‚â•6mm (Mohs preferita)', recurrence: '15-20%', mohs: '‚úì‚úì FORTEMENTE RACCOMANDATA' },
            'var-morphea':       { name: 'BCC Morpheiforme/Sclerosante', risk: 'high', desc: 'Stroma desmoplastico prominente. Aggressivo. Simula cicatrice clinicamente.', margins: '‚â•8-10mm (Mohs GOLD STANDARD)', recurrence: '25-30%', mohs: '‚úì‚úì‚úì INDICAZIONE ASSOLUTA' },
            'var-basosquamous':  { name: 'BCC Basosquamoso (Metatipico)', risk: 'high', desc: 'Componente basaloide + squamoide. Ber-EP4+ focale, EMA+ focale, p40+ nelle aree squamoidi. Eterogeneit√† intratumorale ‚Äî mappare su sezioni multiple. Potenziale metastatico.', margins: '‚â•6mm (Mohs preferita)', recurrence: '20-30%', mohs: '‚úì‚úì FORTEMENTE RACCOMANDATA' },
            'var-mixed':         { name: 'BCC Misto', risk: 'high', desc: 'Combinazione di pattern. Management secondo componente pi√π aggressiva.', margins: 'Secondo sottotipo peggiore', recurrence: 'Secondo componente aggressiva', mohs: 'Se componente aggressiva >10%' }
        };

        let html = '';
        let hasHighRisk = false;
        let hasBasosquamous = false;

        for (const [id, data] of Object.entries(variants)) {
            if (document.getElementById(id)?.checked) {
                if (data.risk === 'high') hasHighRisk = true;
                if (id === 'var-basosquamous') hasBasosquamous = true;
                html += `<div class="variant-card ${data.risk}-risk">
                    <h4>${data.name} ${data.risk === 'low' ? '<span class="badge badge-success">BASSO RISCHIO</span>' : '<span class="badge badge-danger">ALTO RISCHIO</span>'}</h4>
                    <p><strong>Descrizione:</strong> ${data.desc}</p>
                    <p><strong>Margini chirurgici:</strong> ${data.margins}</p>
                    <p><strong>Rischio recidiva:</strong> ${data.recurrence}</p>
                    <p><strong>Mohs surgery:</strong> ${data.mohs}</p>
                </div>`;
            }
        }

        if (hasHighRisk) {
            html = `<div class="alert alert-danger"><strong>‚ö†Ô∏è VARIANTE AD ALTO RISCHIO!</strong><ul>
                <li>Valutare invasione perineurale (S100)</li>
                <li>Imaging pre-op se zona H / invasione profonda</li>
                <li>Follow-up ogni 6 mesi √ó 2 anni, poi annuale</li>
                <li>Consulenza dermatochirurgica per Mohs</li>
                ${hasBasosquamous ? '<li><strong>Basosquamoso:</strong> potenziale metastatico ‚Äî staging linfonodale se >2cm o recidiva</li>' : ''}
            </ul></div>` + html;
        }

        document.getElementById('variant-details').innerHTML = html || '<div class="alert alert-info">Seleziona una variante per i dettagli.</div>';
    }

    </script>
</body>
</html>
